ISSAQUAH, WA – February 10, 2021 – CaaMTech, Inc., announced today that its first patent application, “Compositions and methods comprising a psilocybin derivative“ (US20180221396A1), has been allowed by the US Patent and Trademark Office (USPTO). The notice of allowance is a watershed moment for CaaMTech’s intellectual property division, which has filed in excess of one hundred additional patent…


Previous articleNew Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate
Next articleFeb 10: $SPOR +40.91%, $PSYC +35.42%, $MCUR +23.33%